NCT00006466View on ClinicalTrials.gov

Beta Alethine in Treating Patients With Myeloma

PHASE1/PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Conditions
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Interventions
DRUG

beta alethine

Trial Locations (3)

10011

St. Vincents Comprehensive Cancer Center, New York

20852

Victory Over Cancer, Rockville

30322

Emory Clinic, Atlanta

Sponsors
All Listed Sponsors
lead

LifeTime Pharmaceuticals

INDUSTRY

NCT00006466 - Beta Alethine in Treating Patients With Myeloma | Biotech Hunter | Biotech Hunter